Delay of treatment initiation does not adversely affect survival outcome in breast cancer

Cancer Research and Treatment

Volumn 48, Issue 3, 2016, Pages 962-969

  Yoo, Tae Kyung ^a   Han, Wonshik ^a   Moon, Hyeong Gon ^a   Kim, Jisun ^a,b   Lee, Jun Woo ^a,c   Kim, Min Kyoon ^a,d   Lee, Eunshin ^a,e   Kim, Jongjin ^a,f   Noh, Dong Young ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Kangwon National University   (South Korea)

^e Bundang Jesaeng Hospital   (South Korea)

^f Seoul National University Boramae Hospital   (South Korea)

Author keywords

Breast neoplasms; Survival rate; Time to treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; BREAST BIOPSY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONSULTATION; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; RETROSPECTIVE STUDY; THERAPY DELAY; TIME TO TREATMENT; TRIPLE NEGATIVE BREAST CANCER; TUMOR BIOPSY; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; AGED; BIOPSY; BREAST; BREAST TUMOR; CANCER STAGING; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84981340861     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2015.173     Document Type: Article

References (14)

1. Brazda A, EstroffJ, Euhus D, Leitch AM, Huth J, Andrews V, et al. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010;17 Suppl 3:291-6.
2. McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012; 30:4493-500.
3. Mujar M, Dahlui M, Yip CH, Taib NA. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival? Prev Med. 2013;56:222-4.
4. Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468-76.
5. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516-23.
6. Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012;23: 2731-7.
7. Ganz PA. Quality of life across the continuum of breast cancer care. Breast J. 2000;6:324-30.
8. Eastman A, Tammaro Y, Moldrem A, Andrews V, Huth J, Euhus D, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013;20:1880-5.
9. Birkmeyer JD, Siewers AE, Marth NJ, Goodman DC. Regionalization of high-risk surgery and implications for patient travel times. JAMA. 2003;290:2703-8.
10. Simunovic M, Theriault ME, Paszat L, Coates A, Whelan T, Holowaty E, et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg. 2005;48:137-42.
11. Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27:4671-8.
12. Bardell T, Belliveau P, Kong W, Mackillop WJ. Waiting times for cancer surgery in Ontario: 1984-2000. Clin Oncol (R Coll Radiol). 2006;18:401-9.
13. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779-85.
14. Kawakami J, Hopman WM, Smith-Tryon R, Siemens DR. Measurement of surgical wait times in a universal health care system. Can Urol Assoc J. 2008;2:597-603.